Peripheral Artery Disease Market: Information By Treatment Type (Devices (Angioplasty Balloon, Angioplasty Stents (Stenting), Catheters, Plaque Modification Devices (Atherectomy), Hemodynamic Flow Alteration Devices, Others), Drugs (Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs)) End User (Hospitals and Clinics, Ambulatory Surgery Centers) - Forecast 2027

ID: VPR/HC/1038 Publishing Year: October 2021 Pages: 102 Format:   


Peripheral Artery Disease Market Overview:

The Peripheral Artery Disease Market is projected to grow from USD 19.5 billion in 2020 to reach USD 26 billion by 2027; it is expected to grow at a CAGR of 4.2% from 2020 to 2027.

Market has created a research that examines the Peripheral Artery Disease Market trends that will impact overall market growth. It also offers thorough information on the profitability graph, SWOT analysis, market share, and regional expansion of this company. Furthermore, in the competitive landscape study of this market, the report provides information on the present status of leading market players.

The Peripheral Artery Disease Market is expected to increase significantly by the end of the forecast period, according to a study conducted by FutureWise research analysts. According to the analysis, this industry is expected to grow at a significant rate over the next few years. This study includes vital details on the industry's current overall worth, as well as market segmentation and potential opportunities.

Key Players:

Medtronic accounted for the largest share of the Peripheral Artery Disease Market in 2019. The company mainly focuses on product approvals and launches to strengthen its position in the Peripheral Artery Disease Market. In 2019, the company received US FDA approval for its IN.PACT AV drug-coated balloon (DCB) to treat arteriovenous fistula lesions. Similarly, in 2017, the company received the CE Mark approval for its Valiant Navion thoracic stent graft system. The company also received CE mark approval for the HawkOne 6F Directional Atherectomy System.

Covid-19 Impact:

Despite the availability of emergency and outpatient services in hospitals, the number of patient visits to hospitals has decreased dramatically in recent months. Surgeons conduct a battery of clinical tests before beginning any interventional operation to determine the best treatment for their patients. Patients' visits to hospitals have decreased dramatically as a result of the lockdown in numerous nations. As a result, there are fewer diagnostic tests available. This has resulted in a further drop in sales of Peripheral Vascular Devices.

Drivers:

The rapid progression of Peripheral Arterial Disease in the geriatric population is expected to fuel growth in the Peripheral Artery Disease Market Share in the near future.

The recent spike in product approvals is expected to play a significant influence in driving peripheral artery disease market trends in the future years.

The prevalence of bad eating habits and lifestyles centred on sedentary work is expected to boost the Peripheral Vascular Market Growth in the coming years.

Opportunities:

The growth of insurance coverage is expected to create new prospects for the Global Peripheral Artery Disease Market.

Challenges:

Increased product recalls are expected to stymie the expansion of the Peripheral Vascular Devices Market in the near future.

Market Segmentation:

The market for Peripheral Artery Disease is divided into two categories: kind and geography. Peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories are the different types of peripheral angioplasty balloons. North America (the United States, Canada, and Mexico), Europe (Germany, the United Kingdom, France, Spain, Italy, and the rest of Europe), Asia-Pacific (Japan, China, India, Australia, and the rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa) (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Regional Analysis:

The Americas' rise to the top of the regional market is attributable to the rising prevalence of diabetes, rising healthcare costs, and an increase in obesity patients. Individuals are becoming more prone to Peripheral Artery Disease as a result of a lack of physical activity.



Frequently Asked Questions
Peripheral Artery Disease Market is predicted to grow at 4.2% through forecast period of 2020-2027
By 2027, worth USD 26 billion is estimated for the Global Peripheral Artery Disease Market.
The rapid progression of Peripheral Arterial Disease in the geriatric population is expected to fuel growth in the Peripheral Artery Disease Market Share in the near future.
Medtronic accounted for the largest share of the Peripheral Artery Disease Market in 2019. The company mainly focuses on product approvals and launches to strengthen its position in the Peripheral Artery Disease Market. In 2019, the company received US FDA approval for its IN.PACT AV drug-coated balloon (DCB) to treat arteriovenous fistula lesions. Similarly, in 2017, the company received the CE Mark approval for its Valiant Navion thoracic stent graft system. The company also received CE mark approval for the HawkOne 6F Directional Atherectomy System.

Type Here for table of content.


PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]
PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]